Affymetrix Shares Drop 9 Percent, Caliper Rises | GenomeWeb
Shares in Affymetrix dropped 9 percent for the five-day trading period ended Tuesday. The firm’s stock has been fluctuating between nearly $27 per share and $24 per share for the past couple of months. On Tuesday, Affy’s stock closed at $24.44, its lowest point since closing at $24.21 on May 17.
 
Shares in Caliper Life Sciences rose 8.7 percent for the tracking period. The firm’s stock has risen steadily over the past three weeks.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.